Gemina Laboratories Ltd
CNSX:GLAB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Heritage Foods Ltd
NSE:HERITGFOOD
|
IN |
Gemina Laboratories Ltd
Operating Income
Gemina Laboratories Ltd
Operating Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
G
|
Gemina Laboratories Ltd
CNSX:GLAB
|
Operating Income
-CA$3.9m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
B
|
BioMark Diagnostics Inc
CNSX:BUX
|
Operating Income
-CA$2.1m
|
CAGR 3-Years
1%
|
CAGR 5-Years
-33%
|
CAGR 10-Years
N/A
|
|
|
MedMira Inc
XTSX:MIR
|
Operating Income
-CA$2.4m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
1%
|
|
Gemina Laboratories Ltd
Glance View
Gemina Laboratories Ltd. (Gemina) is a Canada-based biotechnology company. Gemina operates in the In Vitro Diagnostics (IVD) and human wellness monitoring market under the name Gemina Labs. It is engaged in biosensor and diagnostic services with a transformative, patented, proprietary chemistry that powers next-generation testing platforms for a wide range of pathogens that affect human health and wellness. Gemina's technology drives testing platforms that are fast, affordable and accurate, and easily self-administered. Its development pipeline includes platforms for the rapid testing of COVID-19, influenza and other viruses. Gemina is focused on infectious respiratory diseases and the recovery from them. It has developed a first-generation technology (the Generation 1 Technology), which it has included within an initial demonstration product namely: a point-of-care lateral flow assay to test whether a person is infected with COVID-19 (the Legio-XTM COVID Rapid Antigen Test).
See Also
What is Gemina Laboratories Ltd's Operating Income?
Operating Income
-3.9m
CAD
Based on the financial report for Jan 31, 2025, Gemina Laboratories Ltd's Operating Income amounts to -3.9m CAD.
What is Gemina Laboratories Ltd's Operating Income growth rate?
Operating Income CAGR 3Y
-9%
Over the last year, the Operating Income growth was -10%. The average annual Operating Income growth rates for Gemina Laboratories Ltd have been -9% over the past three years .
